Merck Strikes Teva With 3rd Singulair Suit

Law360, New York (January 20, 2009, 12:00 AM EST) -- A Merck & Co. affiliate has filed a third lawsuit over its blockbuster allergy and asthma drug Singulair against Teva Pharmaceuticals USA Inc.

Merck Sharp & Dohme Pharmaceuticals SRL filed the suit on Friday in the U.S. District Court for the District of New Jersey after Teva filed an abbreviated new drug application for generic montelukast sodium oral granules, which Merck believes infringes patents used to make Singulair.

It has filed two other suits in the New Jersey district court to block Teva from marketing a...
To view the full article, register now.